CMRG is a national, not-for-profit research organization dedicated to improving outcomes for people living with multiple myeloma through clinical trials, real-world evidence, and translational research across Canada.

CMRG provides patients with access to innovative clinical trials, supports better use of real-world data to understand treatment outcomes, and helps accelerate the development of new diagnostics and therapies that can improve care in Canada.

CMRG brings together clinical trials and a national real-world evidence database within an integrated research platform, with a Biobank envisioned as a future addition. As this initiative develops, it is intended to strengthen connections between laboratory discoveries, patient outcomes, and clinical practice.

CMRG is made up of more than 25 leading cancer centres across Canada, along with clinicians, researchers, data specialists, and patient partners who work together to advance myeloma research.

The CMRG Database is Canada’s largest prospective real-world dataset for multiple myeloma. It collects information on treatments, outcomes, and safety to help researchers, clinicians, and policymakers better understand how therapies work in everyday care.

The CMRG Biobank represents a strategic aspiration currently in development. The proposed national program would collect, and store patient samples linked to clinical and real-world data, creating a foundation for biomarker discovery, precision medicine, and innovative diagnostic and therapeutic approaches. Further updates will be shared as this initiative progresses.

Patients can participate through CMRG-supported trials or the database at participating centres. Clinicians and partners can collaborate by proposing studies, contributing data, or supporting research through partnerships and funding.